Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder in premenopausal women, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Patients frequently present comorbidities, including obesity, insulin resistance, and impaired glucose and...

Full description

Bibliographic Details
Main Authors:	Lara Mastnak, Rok Herman, Simona Ferjan, Andrej Janež, Mojca Jensterle
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Life
Subjects:	polycystic ovary syndrome prolactin metabolic homeostasis cardiometabolic markers dopamine agonist
Online Access:	https://www.mdpi.com/2075-1729/13/11/2124

Similar Items

Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives
by: Mojca Jensterle, et al.
Published: (2022-08-01)

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
by: Rok Herman, et al.
Published: (2023-02-01)

A Meta-Analysis of Observational Studies on Prolactin Levels in Women with Polycystic Ovary Syndrome
by: Marzieh Saei Ghare Naz, et al.
Published: (2022-11-01)

Metabolic association of serum prolactin in polycystic ovary syndrome: A retrospective analysis of 840 patients in Bangladesh
by: A.B.M. Kamrul-Hasan, et al.
Published: (2024-03-01)

Assessment of Eating Disorders and Eating Behavior to Improve Treatment Outcomes in Women with Polycystic Ovary Syndrome
by: Tea Shehu Kolnikaj, et al.
Published: (2022-11-01)

Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome
by: Haiyan Yang, et al.
Published: (2021-02-01)

Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
by: Oleksandr Voznyak, et al.
Published: (2024-02-01)

Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome
by: Zhirong Zhang, et al.
Published: (2021-08-01)

Seasonal patterns of prolactin, prolactin receptor, and STAT5 expression in the ovaries of wild ground squirrels (<em>Citellus dauricus</em> Brandt)
by: Qingjing Gao, et al.
Published: (2023-10-01)

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study
by: Robert Krysiak, et al.
Published: (2023-04-01)

The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
by: Tea Shehu Kolnikaj, et al.
Published: (2024-01-01)

An Update on Contraception in Polycystic Ovary Syndrome
by: Seda Hanife Oguz, et al.
Published: (2021-04-01)

Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study
by: Robert Krysiak, et al.
Published: (2023-05-01)

Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital
by: Chukwunonso Isaiah Enechukwu, et al.
Published: (2019-09-01)

The Correlation between Luteinizing hormone, Follicle stimulating hormone, Testosterone, and Prolactin Level at Different Depression Level in Polycystic Ovary Syndrome Patients
by: Govand Sh Tawfeeq, et al.
Published: (2019-10-01)

Effects of Dopamine and L-dopa on Ghrelin Gene Expresion in the Hypothalamus and Ovary in a Polycystic Ovarian Syndrome Rat Model
by: Leila Neghaddadgar, et al.
Published: (2024-01-01)

Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels
by: Andrei Adrian Tica, et al.
Published: (2022-12-01)

Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
by: Lukasz Dzialach, et al.
Published: (2024-02-01)

Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome
by: Mutaz Amin, et al.
Published: (2023-08-01)

Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
by: Robert Krysiak, et al.
Published: (2023-08-01)

Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome
by: Rok Herman, et al.
Published: (2020-10-01)

Berberine in the treatment of polycystic ovary syndrome
by: Łukasz Ochyra, et al.
Published: (2022-04-01)

Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions
by: Hung-Yu Chien, et al.
Published: (2023-03-01)

Prolactin and fMRI response to SKF38393 in the baboon
by: Brad Miller, et al.
Published: (2013-10-01)

Gonadotropin Releasing Hormone Agonists versus Antagonists in Women with Polycystic Ovary Disease Undergoing Intracytoplasmic Sperm Injection
by: Onder Sakin, et al.
Published: (2018-11-01)

The Role of Follicular Fluid Thiol/Disulphide Homeostasis in Polycystic Ovary Syndrome
by: Esra Nur Tola, et al.
Published: (2018-08-01)

Estrogen Receptors in Polycystic Ovary Syndrome
by: Xue-Ling Xu, et al.
Published: (2021-02-01)

The effect of alpha-lipoic acid supplementation on anthropometric, glycemic, lipid, oxidative stress, and hormonal parameters in individuals with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials
by: Ahmed Abu-Zaid, et al.
Published: (2024-01-01)

Serum prolactin, Preptin, CCL 18 and genetic polymorphisms in Iraqi women with polycystic ovary syndrome
by: Israa F. Ascar, et al.
Published: (2021-12-01)

Maternal Overweight vs. Polycystic Ovary Syndrome: Disentangling Their Impact on Insulin Action in Pregnancy—A Prospective Study
by: Michael Feichtinger, et al.
Published: (2020-12-01)

Effects of Mindfulness-Based Therapy on Clinical Symptoms and DNA Methylation in Patients with Polycystic Ovary Syndrome and High Metabolic Risk
by: Hana Dema, et al.
Published: (2023-03-01)

Effects of feeding level, milking frequency, and single injection of cabergoline on blood metabolites, hormones, and minerals around dry-off in dairy cows
by: Lorenzo E. Hernández-Castellano, et al.
Published: (2023-04-01)

Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS)
by: Shannon Herbert, et al.
Published: (2023-12-01)

Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) state
by: Genia F. Burchall, et al.
Published: (2019-03-01)

Inter-observer variability in the assessment of ultrasound features of polycystic ovaries
by: Rami Kilani, et al.
Published: (2017-09-01)

Association of Tumor Markers with Total Testosterone in the Serum of Women with Polycystic Ovary Syndrome
by: Jinghua Zhang, et al.
Published: (2022-07-01)

The relationship between intestinal microbiota and polycystic ovary syndrome
by: Katarzyna Korabiusz, et al.
Published: (2019-05-01)

Anxiety and Depression in Women with Polycystic Ovary Syndrome
by: Paweł Dybciak, et al.
Published: (2022-07-01)

Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2013-12-01)